Bill.com To Buy Invoice2go In $625 Mln Deal – Quick Facts

Bill.com (BILL), a provider of cloud-based software, announced Monday that it has signed a definitive agreement to acquire Invoice2go in a stock and cash transaction valued at about $625 million.

The consideration includes 75% in Bill.com Common Stock and 25% in cash.

Invoice2go is a mobile-first accounts receivable or AR software provider that empowers small businesses and freelancers to grow their client base, manage invoicing and payments, and build their brand, among others. It has offices in Sydney, Australia and Palo Alto, California.

The transaction has been approved by the Boards of Directors of both Invoice2go and Bill.com.

The deal is expected to close by the end of this calendar year, subject to receipt of regulatory approvals and other customary closing conditions.

Bill.com expects the acquisition to enhance its current accounts receivable offering. The deal supports Bill.com’s mission to make it simple to connect and do business.

Online library Go1 raises $200 million from SoftBank Vision Fund 2, others

(Reuters) – Go1, an online library of learning resources, said on Monday it had raised $200 million in fresh capital in a funding round led by SoftBank Vision Fund 2, AirTree Ventures and Salesforce Ventures.

The latest round valued the company at more than $1 billion, it said.

Creatd Shares Gains 15%

Shares of nano-cap company Creatd Inc. (CRTD) are up 15% on Monday morning despite no stock-related statement from the company.

CRTD is currently trading at $3.70, up $0.51 or 15.9875%, on the Nasdaq, on a volume of 18 million shares, far above the average volume of 2.4 million shares. The stock has traded between $2.10 and $7.81 in the 52 week period. The stock has dropped 20% in that period.

Creatd is a technology company that focuses on the development of digital communities, marketing branded digital content, and e-commerce opportunities.

U.S. Homebuilder Confidence Unexpectedly Edges Lower In July

Reflecting supply-side challenges related to building materials, regulation and labor, the National Association of Home Builders released a report on Monday showing an unexpected dip in U.S. homebuilder confidence in the month of July.

The report showed the NAHB/Wells Fargo Housing Market Index edged down to 80 in July from 81 in June. The modest decrease surprised economists, who had expected the index to inch up to 82.

With the unexpected drop, the housing market index slipped to its lowest level since hitting 78 in August of 2020.

“Builders are contending with shortages of building materials, buildable lots and skilled labor as well as a challenging regulatory environment,” said NAHB Chief Economist Robert Dietz.

He added, “This is putting upward pressure on home prices and sidelining many prospective home buyers even as demand remains strong in a low-inventory environment.”

The unexpected decrease by the housing market index came as the component measuring traffic of prospective buyers tumbled to 65 in July from 71 in June.

The index gauging current sales conditions also edged down to 86 in July from 87 in June, while the gauge charting sales expectations in the next six months rose to 81 from 79.

On Tuesday, the Commerce Department is scheduled to release a separate report on new residential construction in the month of June.

Housing starts are expected to jump by 1.6 percent to an annual rate of 1.597 million, while building permits are expected to climb by 1 percent to an annual rate of 1.700 million.

Britain records 39,950 new COVID-19 cases, 19 deaths

LONDON (Reuters) – Britain recorded 39,950 new coronavirus infections on Monday, and 19 deaths within 28 days of a positive test, official government data showed.

That compared to 48,161 cases and 25 deaths reported a day earlier.

Aethlon Medical Gains 10%

Shares of Aethlon Medical Inc. (AEMD) is currently trading at $4.15, up 39 cents or 10.61%, with trading volume rising over 3.80 million versus an average volume of 5.54 million shares. The stock has been trading in the range of $1.22 – $12.49 for the past one year.

There are no recent company-specific news that could be attributed to today’s stock movement.

The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals.

Cash position:

At year-end 2020, the company had zero debt and cash of roughly $12.1 million.

Tractor Supply Drops Despite Upbeat Results

Tractor Supply Co. (TSCO) shares are sliding on Monday morning trade despite the company reporting second-quarter results that beat estimates.

The company reported quarterly net income of $370.02 million, up 10.27 percent from $338.68 million a year ago. On a per-share basis, earnings increased to $3.21 from $2.92 in the prior year.

Net sales increased to $3.601 billion from $3.176 billion in the previous year.
Wall Street were looking for earnings of $2.92 per share on sales of $3.44 billion. Analysts’ estimates typically exclude special items.

Tractor Supply raised its full-year earnings, net sales and comparable store sales projection on improved performance in the first half of 2021.

The company now projects fiscal earnings in a range of $7.70 to $8.00 per share on net sales between $12.1 billion and $12.3 billion, with comparable-store sales growth of 11 to 13 percent.

The earlier projection was for earnings in a range of $7.05 to $7.40 per share on net sales between $11.4 billion and $11.7 billion, with comparable-store sales growth of 5 to 8 percent.

Analysts expect earnings of $7.38 per share on sales of $11.64 billion for the year.

Currently, shares are at $177.11, down 6.20 percent from the previous close of $189.00 on a volume of 1,085,193. The shares have traded in a range of $127.78-$200.75 on average volume of 984,500.